on Friday announced its Q4FY25 earnings where the company reported a net profit growth of 53.5% to Rs 390 crore versus Rs 254 crore in the year ago period. The profit is attributable to the owners of the company and has beaten Street's estimates of Rs 374 crore.
The company's board recommended a final dividend of Rs 10 equity share for FY2024-25.
The board has fixed the record date on August 19, 2025 for the purpose of determining the names of the eligible shareholders for the final dividend.
The revenue from operations was reported at Rs 5,592 crore which was a 13% uptick over Rs 4,944 crore reported in the corresponding period of the previous financial year.
Company' Profit After Tax (PAT) increased 5% on a sequential basis versus 372 crore reported in Q3FY25 while the revenue from operations was marginally up by 1.2% over versus Rs 5,527 crore reported in the October-December quarter of FY25.
Apollo Hospitals incurred expenses of Rs 5,148 crore in the quarter under review versus Rs 5,060 crore in Q3FY25 and Rs 4,612 crore in Q4FY24. The expenses were made under the heads like cost of materials consumed, Changes In Inventories of stock-In-trade, employee benefits expense and finance cost.
Segment revenue
The company's revenue comes from healthcare services, retail health & diagnostics and digital health & pharmacy distribution.
-
Bilal Qureshi says sacrifice should be for Allah, not for show
-
iPhone SE fans unimpressed with new iPhone 16e, netizens question price of new Apple device- The Week
-
Oppo Reno 12 5G: 50MP camera and 5000mAh battery smartphone bought for less than 20000 rupees
-
Realme GT 7 and GT 7T Now Available in India: Prices, Specs, and Offers Unveiled
-
Are Any Harley-Davidson Bikes Made In India?
